Development Level

Tchem 4 | 1,890
Tbio 1 | 10,625
Tclin 1 | 602

Disease

Cancer 4 | 2,346
ovarian cancer 4 | 8,484
Anemia 3 | 252
non-small cell lung cancer 3 | 2,798
Achalasia 2 | 11
Allergic hypersensitivity disease 2 | 123
Arthritis 2 | 248
Asthma 2 | 349
Barrett's esophagus 2 | 183
Bile reflux 2 | 8
Carcinoma 2 | 2,147
Cerebrovascular disease 2 | 231
Chronic intestinal vascular insufficiency 2 | 12
Constipation 2 | 43
Coronary artery disease 2 | 240
Diarrhea 2 | 155
Duodenitis 2 | 8
Duodenogastric reflux 2 | 8
Dyskinesia of esophagus 2 | 3
Dyspepsia 2 | 34
Eosinophilia 2 | 65
Esophageal atresia 2 | 25
Esophageal varix 2 | 10
Esophagitis 2 | 26
Gastric antral vascular ectasia 2 | 11
Gastric outlet obstruction 2 | 6
Gastritis 2 | 44
Gastroenteritis 2 | 46
Gastroesophageal reflux disease 2 | 37
Gastroparesis 2 | 20
Hiatus hernia 2 | 7
Hypersensitivity reaction type II disease 2 | 235
Inflammatory bowel disease 2 | 142
Irritable bowel syndrome 2 | 59
Kidney disease 2 | 396
Laryngitis 2 | 2
Liver disease 2 | 219
Osteopetrosis 2 | 40
Osteoporosis 2 | 257
Pain disorder 2 | 13
Peptic ulcer disease 2 | 11
Peritonitis 2 | 37
Pernicious anemia 2 | 10
Pneumonia 2 | 133
Polycythemia 2 | 19
Varicose veins 2 | 15
Vitamin B12 deficiency 2 | 20
X-linked myopathy with excessive autophagy 2 | 2
Zollinger-Ellison Syndrome 2 | 14
atypical teratoid / rhabdoid tumor 2 | 4,369
cutaneous lupus erythematosus 2 | 1,056
cystic fibrosis 2 | 1,665
diabetes mellitus 2 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
invasive ductal carcinoma 2 | 2,950
lung adenocarcinoma 2 | 2,713
lung cancer 2 | 4,466
medulloblastoma, large-cell 2 | 6,234
pancreatic cancer 2 | 2,300
psoriasis 2 | 6,685
Atopic dermatitis 1 | 944
Autoimmune polyendocrine syndrome 1 | 6
Duodenal Ulcer due to H. Pylori 1 | 7
Duodenal ulcer disease 1 | 7
Erosive esophagitis 1 | 6
Gastric Hypersecretory Conditions 1 | 5
Gastric ulcer 1 | 34
Gout 1 | 93
IGA Glomerulonephritis 1 | 454
Lupus erythematosus 1 | 80
Maintenance of Healing Duodenal Ulcer 1 | 7
Multiple endocrine adenomas 1 | 3
Osteoarthritis in Patients at High Ulcer Risk 1 | 7
Peptic reflux disease 1 | 4
Peptic ulcer 1 | 22
Persistent generalized lymphadenopathy 1 | 15
Primary polycythemia 1 | 7
Rheumatoid Arthritis in Patient at High Ulcer Risk 1 | 7
Systemic mast cell disease 1 | 12
TOBACCO ADDICTION, SUSCEPTIBILITY TO (finding) 1 | 12
Tularemia 1 | 22
Vascular disease 1 | 281
Von Hippel-Lindau disease 1 | 11
acute quadriplegic myopathy 1 | 1,157
adult high grade glioma 1 | 2,148
chronic lymphosyte leukemia 1 | 232
fascioscapulohumeral muscular dystrophy 1 | 100
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
hepatocellular carcinoma 1 | 532
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
medulloblastoma 1 | 1,524
mucosa-associated lymphoid tissue lymphoma 1 | 480
nasopharyngeal carcinoma 1 | 1,056
oligodendroglioma 1 | 2,849
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
pituitary cancer 1 | 1,972
sarcoidosis 1 | 358
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,557

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Liver and Pancreas 6 | 18,136
Male tissues 6 | 17,969
Nervous System 6 | 18,561
Respiratory system 6 | 17,484
Skin and soft tissues 6 | 18,115
Urinary Tract 6 | 18,444

Target Family

Non-IDG 4 | 11,971
Transporter 2 | 473

Grant Application

5R01DK097075-03 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Potassium-transporting ATPase alpha chain 2 ATP12A Tchem Transporter -3.77726 5982.8 71
Egl nine homolog 3 EGLN3 Tchem Non-IDG -1.98955 102.9 331
Potassium-transporting ATPase alpha chain 1 ATP4A Tclin Transporter -3.77806 5994.1 21
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Egl nine homolog 1 EGLN1 Tchem Non-IDG -2.43030 287.5 363
Egl nine homolog 2 EGLN2 Tchem Non-IDG -1.97052 0.00000 265